APOE and Alzheimer disease: Importantly, the cumulative improvements in risk prediction (due to inclusion of the new variants in the GRS) led to a 1.6- to 1.9-fold increase in the AD risk from the lowest to the highest decile, in addition to the effects of age and APOE status.